BlackRock’s Lisata Therapeutics LSTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $187K | Hold |
54,857
| – | – | ﹤0.01% | 4831 |
|
|
2026
Q1 | $275K | Hold |
54,857
| – | – | ﹤0.01% | 4680 |
|
|
2025
Q4 | $102K | Sell |
54,857
-33
| -0.1% | -$73 | ﹤0.01% | 4903 |
|
|
2025
Q3 | $144K | Buy |
54,890
+33
| +0.1% | +$83 | ﹤0.01% | 4751 |
|
|
2025
Q2 | $159K | Hold |
54,857
| – | – | ﹤0.01% | 4724 |
|
|
2025
Q1 | $129K | Sell |
54,857
-1,156
| -2% | -$3.13K | ﹤0.01% | 4703 |
|
|
2024
Q4 | $167K | Hold |
56,013
| – | – | ﹤0.01% | 4657 |
|
|
2024
Q3 | $168K | Hold |
56,013
| – | – | ﹤0.01% | 4564 |
|
|
2024
Q2 | $194K | Hold |
56,013
| – | – | ﹤0.01% | 4556 |
|
|
2024
Q1 | $175K | Sell |
56,013
-237
| -0.4% | -$702 | ﹤0.01% | 4618 |
|
|
2023
Q4 | $154K | Sell |
56,250
-556
| -1% | -$1.31K | ﹤0.01% | 4703 |
|
|
2023
Q3 | $122K | Hold |
56,806
| – | – | ﹤0.01% | 4797 |
|
|
2023
Q2 | $210K | Hold |
56,806
| – | – | ﹤0.01% | 4721 |
|
|
2023
Q1 | $184K | Hold |
56,806
| – | – | ﹤0.01% | 4799 |
|
|
2022
Q4 | $144K | Sell |
56,806
-1
| -0% | -$4 | ﹤0.01% | 4939 |
|
|
2022
Q3 | $263K | Sell |
56,807
-35
| -0.1% | -$254 | ﹤0.01% | 4903 |
|
|
2022
Q2 | $452K | Sell |
56,842
-9,950
| -15% | -$81.9K | ﹤0.01% | 4800 |
|
|
2022
Q1 | $723K | Sell |
66,792
-476
| -0.7% | -$5.45K | ﹤0.01% | 4773 |
|
|
2021
Q4 | $849K | Buy |
67,268
+527
| +0.8% | +$8.14K | ﹤0.01% | 4718 |
|
|
2021
Q3 | $1.22M | Buy |
66,741
+4
| +0% | +$78 | ﹤0.01% | 4505 |
|
|
2021
Q2 | $1.61M | Sell |
66,737
-2,461
| -4% | -$58.3K | ﹤0.01% | 4362 |
|
|
2021
Q1 | $2M | Buy |
69,198
+67,187
| +3,341% | +$2.04M | ﹤0.01% | 4285 |
|
|
2020
Q4 | $43K | Buy |
2,011
+17
| +0.9% | +$403 | ﹤0.01% | 4691 |
|
|
2020
Q3 | $54K | Hold |
1,994
| – | – | ﹤0.01% | 4602 |
|
|
2020
Q2 | $53K | Sell |
1,994
-21
| -1% | -$618 | ﹤0.01% | 4572 |
|
|
2020
Q1 | $55K | Buy |
2,015
+38
| +2% | +$1.47K | ﹤0.01% | 4447 |
|
|
2019
Q4 | $74K | Buy |
1,977
+9
| +0.5% | +$323 | ﹤0.01% | 4489 |
|
|
2019
Q3 | $76K | Buy |
1,968
+28
| +1% | +$1.09K | ﹤0.01% | 4483 |
|
|
2019
Q2 | $66K | Sell |
1,940
-1,443
| -43% | -$64.1K | ﹤0.01% | 4545 |
|
|
2019
Q1 | $185K | Sell |
3,383
-71
| -2% | -$4.67K | ﹤0.01% | 4253 |
|
|
2018
Q4 | $184K | Buy |
3,454
+10
| +0.3% | +$695 | ﹤0.01% | 4248 |
|
|
2018
Q3 | $304K | Buy |
3,444
+75
| +2% | +$6.15K | ﹤0.01% | 4236 |
|
|
2018
Q2 | $327K | Buy |
3,369
+239
| +8% | +$16.9K | ﹤0.01% | 4201 |
|
|
2018
Q1 | $274K | Sell |
3,130
-23
| -0.7% | -$1.59K | ﹤0.01% | 4146 |
|
|
2017
Q4 | $166K | Buy |
3,153
+235
| +8% | +$11.8K | ﹤0.01% | 4248 |
|
|
2017
Q3 | $157K | Sell |
2,918
-39
| -1% | -$2.37K | ﹤0.01% | 4279 |
|
|
2017
Q2 | $206K | Buy |
2,957
+1,178
| +66% | +$83.2K | ﹤0.01% | 4237 |
|
|
2017
Q1 | $134K | Buy |
+1,779
| New | +$123K | ﹤0.01% | 4287 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 3189 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3149 |
|
Other funds holding LSTA
YCM
CL
DAM
RC
VF
GS
BlackRock's LSTA Position: Q2 2026 in Review
BlackRock held its Lisata Therapeutics (LSTA) position steady in Q2 2026 at 54,857 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #4831.
BlackRock first reported a position in LSTA in Q1 2017 and has held it in 38 quarters since. The position peaked at $2M in Q1 2021. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.
- BlackRock held 54,857 shares of Lisata Therapeutics worth $187K as of Q2 2026.
- BlackRock left its Lisata Therapeutics share count unchanged in Q2 2026.
- Lisata Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4831 holding.
- BlackRock first reported a position in Lisata Therapeutics in Q1 2017 and has held it in 38 quarters since.
- BlackRock's Lisata Therapeutics position peaked at $2M in Q1 2021.
- 31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.